Canakinumab Subcutaneous and Hydroxyprogesterone Caproate Injection
Determining the interaction of Canakinumab Subcutaneous and Hydroxyprogesterone Caproate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: hydroxyprogesterone
Brand name: Makena, Makena Auto-Injector, Hylutin, Delta-Lutin, Duralutin, Hyprogesterone, Prodrox
Synonyms: Hydroxyprogesterone injection, Hydroxyprogesterone Caproate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Hydroxyprogesterone Caproate Injection (Makena)
- Canakinumab Subcutaneous-Hydroxyprogesterone injection
- Canakinumab Subcutaneous-Hydroxyprogesterone Intramuscular
- Canakinumab Subcutaneous-Hydroxyquinoline vaginal
- Canakinumab Subcutaneous-Hydroxyurea
- Canakinumab Subcutaneous-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Hydroxyprogesterone Caproate Injection-Canasa
- Hydroxyprogesterone Caproate Injection-Canasa Pac rectal
- Hydroxyprogesterone Caproate Injection-Canasa rectal
- Hydroxyprogesterone Caproate Injection-Cancidas
- Hydroxyprogesterone Caproate Injection-Candesartan
- Hydroxyprogesterone Caproate Injection-Candesartan and Hydrochlorothiazide